Funding delays for Alzheimer's research, primarily impacting the University of Washington's brain bank, threaten to halt crucial advancements and patient care. The Trump administration's slowdown of grant approvals has left researchers scrambling for alternative funding sources to continue their work, jeopardizing decades of progress and potentially causing a brain drain of talented scientists. The situation casts uncertainty over the future of numerous research programs, including those actively treating patients like 79-year-old Andrea Gilbert, who donated her brain for Alzheimer's research.

Prepared by Olivia Bennett and reviewed by editorial team.